z-logo
open-access-imgOpen Access
Re: Long-term control in a patient with metastatic lung adenocarcinoma after discontinuation of nivolumab
Author(s) -
Rubén Pampín Sánchez,
FJ Barbazán-Vázquez,
Beatriz Fernández-González,
B Rodríguez-de-Castro,
C Aparicio-Carreño,
Teresa Sampedro-Gimeno
Publication year - 2021
Publication title -
journal of oncology pharmacy practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.548
H-Index - 34
eISSN - 1477-092X
pISSN - 1078-1552
DOI - 10.1177/10781552211004680
Subject(s) - nivolumab , medicine , discontinuation , metastatic adenocarcinoma , adenocarcinoma , oncology , lung , metastatic melanoma , term (time) , lung cancer , intensive care medicine , adenocarcinoma of the lung , immunotherapy , cancer , physics , quantum mechanics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Empowering knowledge with every search

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom